Conditions: Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 239
Healthy volunteers: no

Brief summary:
A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.

Detailed description:
A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in 110 Metformin-treated Patients with Type 2 Diabetes

Arms:
arm 1: Once weekly injected exenatide arm 2: Placebo comparator

Interventions: intervention 1: Bydureon intervention 2: Placebo
Intervention descriptions: intervention 1: Once weekly injection of 2mg bydureon (extended release exenatide) for 10 weeks. intervention 2: Placebo

Protocol document: